GPL Holdings, Inc. (GPLL)
OTCMKTS · Delayed Price · Currency is USD
0.0113
-0.0096 (-45.93%)
At close: Sep 17, 2026
GPL Holdings Market Cap
GPL Holdings has a market cap or net worth of $2.56 million as of November 13, 2026. It is the 47,185th most valuable company in the world and the 6,243rd biggest in the United States. Its market cap has decreased by 35.80% in one year.
Market Cap
2.56M
Enterprise Value
n/a
Revenue
376.54K
Global Rank
Country Rank
#6,243 United States
PE Ratio
n/a
ChartMarket Cap Chart
Since November 19, 2007, GPL Holdings's market cap has increased from 1.76M to 2.56M, an increase of 45.86%. That is a compound annual growth rate of 2.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 2.95M | -61.08% |
| Dec 31, 2025 | 7.58M | 5,466.65% |
| Dec 23, 2024 | 136.13K | -54.57% |
| Dec 23, 2022 | 299.69K | -2.63% |
| Dec 29, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Institute of Biomedical Research | 3.30M |
| VitaSpring Biomedical | 3.21M |
| Pacific Software | 3.12M |
| Abpro Holdings | 3.01M |
| Orgenesis | 2.94M |
| BioAtla | 2.82M |
| Vaccinex | 2.68M |
| Bioxytran | 2.52M |